about
Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophyPeroxisomal alterations in Alzheimer's diseaseCD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy.Mutations, clinical findings and survival estimates in South American patients with X-linked adrenoleukodystrophy.Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient micePathophysiology of X-linked adrenoleukodystrophy.ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapyMammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance.Clinical utility gene card for: adrenoleukodystrophy.Induced pluripotent stem cells to model and treat neurogenetic disordersBezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesisClinical reasoning: a 56-year-old man with progressive spasticityClinical manifest x-linked recessive adrenoleukodystrophy in a female.General aspects and neuropathology of X-linked adrenoleukodystrophy.Pharmacogenetics of drug transporters in the enterohepatic circulation.Advances and pitfalls of cell therapy in metabolic leukodystrophies.Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy.A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.Inherited and acquired disorders of myelin: The underlying myelin pathology.Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.Inflammatory profile in X-linked adrenoleukodystrophy patients: Understanding disease progression.Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase.A de-novo large deletion of 2.8 kb produced in the ABCD1 gene causing adrenoleukodystrophy disease.Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders.
P2860
Q33897085-1E0BD65A-D407-4A4B-915B-14647642A294Q33905478-02DBCE61-DD07-4E81-971D-2276896AC050Q34130740-6256C3CE-7F2A-4C1D-BA03-F7146D7E2499Q34222232-7B7AB02E-B4A4-4CED-9F06-05CE2A318EAFQ34257373-9D5B57C0-1157-4B8A-89AF-58B20C7464FDQ34390414-3A3EF2B2-C053-429F-904E-93A9B6B2CF50Q34598483-E2B5C9C5-91A0-44EC-82C0-320FF6D41E17Q35636076-72BAE685-8379-4ACC-8946-A49C1EEA9D06Q35768334-CE0A8D72-002B-418E-9485-B6F0692139A0Q36131883-967DCBB3-FF75-4CE5-BD62-9B6DBE19ECEFQ36315284-E94C39E9-4B66-4564-8590-FDC29E2F108BQ36632900-B88B3C03-9ED2-4A5B-A03B-CDDB030CA925Q36687160-77D5799C-D209-4F92-9727-61CB52AFF920Q36995509-7DA3C27A-EE99-4501-92C8-3158A80A657AQ37772224-8255752C-C8A3-457B-B9EE-A931D28652DBQ37880875-A61F7F34-8AEA-4ED0-AFF3-89E0EE8F50D7Q38046023-C87CB97D-645C-4779-AA21-084BA0BE546BQ38546277-25D6342F-CB22-4313-8A5C-91B4F155433AQ38716382-4E896F56-A956-486D-9541-D2A24A50987CQ38805611-3094B810-247F-4C59-8D6F-70E5B2658656Q38867787-F85A2EA1-287C-478B-B003-FF276701A69EQ43448425-4125909E-A8CA-465D-B379-81FE6E72BAA2Q47801072-49C5AD70-B573-4B86-A184-832ACC75BD21Q48102083-04A9D975-9881-4EB6-A753-7A0D19D64F34Q48111114-E8063D90-37F6-4D25-A216-E5B17CA93267Q48702772-076C3EB4-F805-4EF9-A309-D2A114BF7ABBQ48986828-06E1D24D-7674-4484-BB42-EEB1C971C0AB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biochemical aspects of X-linked adrenoleukodystrophy.
@en
Biochemical aspects of X-linked adrenoleukodystrophy.
@nl
type
label
Biochemical aspects of X-linked adrenoleukodystrophy.
@en
Biochemical aspects of X-linked adrenoleukodystrophy.
@nl
prefLabel
Biochemical aspects of X-linked adrenoleukodystrophy.
@en
Biochemical aspects of X-linked adrenoleukodystrophy.
@nl
P2860
P1433
P1476
Biochemical aspects of X-linked adrenoleukodystrophy
@en
P2860
P304
P356
10.1111/J.1750-3639.2010.00391.X
P577
2010-07-01T00:00:00Z